Concepedia

Etsuko Fujii

EF

19

Publications

885

Citations

16

H-Index

2002

Active since

Affiliations

Chugai Pharma (United States)(Current)

Central Institute for Experimental Animals

BoZo Research Center (Japan)

The University of Tokyo

Etsuko Fujii is an author at Chugai Pharma (United States) specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2002–2023

19

Publications

19

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis

Atsuhiko Kato, Etsuko Fujii, Takeshi Watanabe et al. · Journal of Dermatological Science · 2014 · 105 citations

, , +7

Anti‐<scp>IL</scp>‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice

Keiko Kasutani, Etsuko Fujii, Satoko Ohyama et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text

Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment

Futa Mimoto, K. Tatsumi, Shun Shimizu et al. · Cell Reports · 2020 · 62 citations · Full text

, , +15

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 54 citations · Full text

Rows per page

1–5 of 19